HARMONY BIOSCIENCES HOLDINGS, INC. Earnings Per Share (Basic)
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) reported Earnings Per Share (Basic) of $1.30 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-04
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-06-30 was $1.30, a 88.41% increase year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, basic for the quarter ending 2026-03-31 was $0.56, a 29.11% decline year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-09-30 was $0.88, a 8.64% increase year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, basic for the quarter ending 2025-06-30 was $0.69, a 245.00% increase year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, basic for fiscal 2025 was $2.76, a 7.81% increase from fiscal 2024.
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, basic for fiscal 2024 was $2.56, a 17.97% increase from fiscal 2023.
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, basic for fiscal 2023 was $2.17, a 29.32% decline from fiscal 2022.
- HARMONY BIOSCIENCES HOLDINGS, INC. earnings per share, basic for fiscal 2022 was $3.07, a 411.67% increase from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.30 10-Q · filed 2026-08-04 | $1.86 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | $0.56 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $2.76 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $0.88 10-Q · filed 2025-11-04 | $2.36 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | $0.69 10-Q · filed 2026-08-04 | $1.49 10-Q · filed 2026-08-04 | ||
| 2025-03-31 | $0.79 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $2.56 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $0.81 10-Q · filed 2025-11-04 | $1.69 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $0.20 10-Q · filed 2025-08-05 | $0.88 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | $0.68 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $2.17 10-K · filed 2026-02-24 | |||
| 2023-09-30 | $0.64 10-Q · filed 2024-10-29 | $1.71 10-Q · filed 2024-10-29 | ||
| 2023-06-30 | $0.57 10-Q · filed 2024-08-06 | $1.07 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $0.49 10-Q · filed 2024-04-30 | |||
| 2022-12-31 | $3.07 10-K · filed 2025-02-25 | |||
| 2022-09-30 | $1.48 10-Q · filed 2023-10-31 | $2.25 10-Q · filed 2023-10-31 | ||
| 2022-06-30 | $0.40 10-Q · filed 2023-08-01 | $0.76 10-Q · filed 2023-08-01 | ||
| 2022-03-31 | $0.36 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | $0.39 derived: net income ÷ weighted average shares · filed 2024-02-22 | $0.23 derived: net income ÷ weighted average shares · filed 2024-02-22 | $0.47 derived: net income ÷ weighted average shares · filed 2024-02-22 | $0.60 10-K · filed 2024-02-22 |
| 2021-09-30 | -$0.17 10-Q · filed 2022-11-01 | $0.08 derived: net income ÷ weighted average shares · filed 2022-11-01 | $0.21 10-Q · filed 2022-11-01 | $0.20 derived: net income ÷ weighted average shares · filed 2023-02-21 |
| 2021-06-30 | $0.25 10-Q · filed 2022-08-02 | $0.38 10-Q · filed 2022-08-02 | $0.37 derived: net income ÷ weighted average shares · filed 2023-02-21 | $0.34 derived: net income ÷ weighted average shares · filed 2023-02-21 |
| 2021-03-31 | $0.13 10-Q · filed 2022-05-03 | $0.13 derived: net income ÷ weighted average shares · filed 2023-02-21 | $0.06 derived: net income ÷ weighted average shares · filed 2023-02-21 | -$0.19 derived: net income ÷ weighted average shares · filed 2023-02-21 |
| 2020-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2023-02-21 | -$0.10 derived: net income ÷ weighted average shares · filed 2023-02-21 | -$0.47 derived: net income ÷ weighted average shares · filed 2023-02-21 | -$2.48 10-K · filed 2023-02-21 |
| 2020-09-30 | -$0.14 10-Q · filed 2021-11-09 | -$0.77 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$4.15 10-Q · filed 2021-11-09 | -$8.19 derived: net income ÷ weighted average shares · filed 2022-02-28 |
| 2020-06-30 | -$1.34 10-Q · filed 2021-08-10 | -$7.63 10-Q · filed 2021-08-10 | -$13.55 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$18.81 derived: net income ÷ weighted average shares · filed 2022-02-28 |
| 2020-03-31 | -$6.30 10-Q · filed 2021-05-11 | -$12.21 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$17.48 derived: net income ÷ weighted average shares · filed 2022-02-28 | |
| 2019-12-31 | -$5.92 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$11.18 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$24.07 10-K · filed 2022-02-28 | |
| 2019-09-30 | -$5.26 10-Q · filed 2020-11-12 | -$18.15 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |